Patent · US Active

HCV protease inhibitors

US8765667B2 · kind B2 · utility

2Cited by
0References
26Claims
0Family size

Inventors

Key dates

Filing dateAug 20, 2009
Grant dateJul 1, 2014
Priority date
Expiry dateJul 20, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/0804
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel compounds that are potent inhibitors of hepatitis C virus protease are provided. Pharmaceutical compositions containing one or more of these inhibitors, methods of preparing the inhibitors and methods of using the inhibitors to treat hepatitis C and related disorders also are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.